Immediate Impact
2 by Nobel laureates 1 from Science/Nature 51 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Works of Jinhua Long being referenced
Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2‐RhoA‐cofilin1 pathway
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jinhua Long | 259 | 224 | 288 | 276 | 41 | 697 | |
| Xinyu Wen | 196 | 100 | 429 | 134 | 40 | 812 | |
| Baiyao Wang | 190 | 92 | 408 | 176 | 34 | 715 | |
| Dengxiong Li | 151 | 79 | 289 | 237 | 68 | 578 | |
| Qiao Xiong | 174 | 92 | 333 | 273 | 30 | 704 | |
| Songcheng Yin | 233 | 142 | 204 | 193 | 30 | 594 | |
| Wataru Sakamoto | 378 | 265 | 378 | 126 | 65 | 785 | |
| Huy Q. Ta | 157 | 130 | 260 | 150 | 24 | 590 | |
| Xiaoming Hou | 168 | 108 | 368 | 121 | 56 | 712 | |
| Gangga Anuraga | 127 | 77 | 409 | 203 | 36 | 605 | |
| Yen‐Rei Yu | 137 | 178 | 313 | 209 | 25 | 676 |
All Works
Login with ORCID to disown or claim papers
Loading papers...